200-301-A33

antibody from Rockland Immunochemicals, Inc.

Targeting: GAPDHS GAPD2, GAPDH-2, GAPDS

Immunocytochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

200-301-A33

Provider

Rockland Immunochemicals, Inc.

Proper citation

Rockland Cat#200-301-A33, RRID:AB_11181725

Product name

Anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (Mouse) Monoclonal Antibody - 200-301-A33

Antibody type

Monoclonal

Vial size

100 µl

References

Submitted references

Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.

Nahrendorf M, Sosnovik D, Chen JW, Panizzi P, Figueiredo JL, Aikawa E, Libby P, Swirski FK, Weissleder R
Circulation 2008 Mar 4;117(9):1153-60

Immunocytochemistry

Supportive validation

Submitted by

Rockland Immunochemicals, Inc. (provider)

Main image

Experimental details

Immunofluorescence Microscopy of Mouse Anti-Glyceraldehyde 3-Phosphate Dehydrogenase Antibody. Tissue: Human neuroblastoma SH-SY5Y cells. Fixation: 0.5% PFA. Antigen retrieval: not required. Primary antibody: GAPDH antibody at 10 µg/mL for 1 h at RT. Secondary antibody: Fluorescein mouse secondary antibody at 1:10,000 for 45 min at RT. Localization: GAPDH is cytoplasmic. Staining: Anti-GAPDH (green), chicken antibody to neurofilament NF-H (red) and DNA (blue).

Sample type

IF Microscopy